Federation des caisses Desjardins du Quebec
Position in RGC — Regencell Bioscience Holdings Ltd
CIK 2022297
LEVIS, A8
Position in RGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,070
-$39,664 QoQ
Shares Held
2,803
+25.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 35 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $38,102,659 across 31 Drug Manufacturers - Specialty & Generic names. RGC ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
317,729 | $10,764,656 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
11,689 | $6,333,449 | |
| 3 | ZTS |
Zoetis Inc.
|
85,213 | $6,123,404 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
23,904 | $4,028,778 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
31,533 | $2,610,301 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
496,836 | $2,449,401 | |
| 7 | VTRS |
Viatris Inc
|
104,424 | $1,658,251 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
62,505 | $1,538,247 |
All Filings in RGC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,070 | 2,803 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $56,734 | 2,231 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||